This site is intended for Healthcare Professionals only

valproate

safety-alert-summary

New valproate safety materials released by MHRA

Updated regulatory measures are now in place to reduce the known harms from valproate.

09 Feb 2024 , 3 Min Article

valproate-1280x720

New study suggests risk of disorders in children fathered by men taking valproate

The MHRA advises that, as a precaution, male patients on valproate who are planning a family in the next year should talk to their healthcare professional

16 Jan 2024 , 1 Min Article

valproate-1280

MHRA sets out new measures on the prescribing of valproate

From January next year, valproate must not be prescribed to new male or female patients under the age of 55 unless certain conditions are met.

06 Dec 2023 , 1 Min Article

valproate summary.jpg

PSNC announces mandatory valproate audit for 2022-23

Pharmacies must complete a six-week audit before March 31

15 Nov 2022 , 1 Min Article

pregnant woman summary.jpg

Clinical audit will focus on valproate harm reduction in 2021-22

Audit will aim to reduce potential harm caused by taking valproate during pregnancy.

17 Nov 2021 , 1 Min Article

Woman concerned 620.jpg

GPhC urges pharmacies to have valproate safeguards in place

The GPhC has reminded pharmacy teams to ensure they have safeguards in place when prescribing valproate to patients.

21 Jun 2021 , 1 Min Article

Pharmacist phone 620.jpg

MHRA: Errors on batches of valproate packs

Some batches of Syonell 250mg and 500mg gastro-resistant tablets have product packaging information errors.

04 May 2021 , 1 Min Article

Change privacy settings